Background:Otologic and vestibular symptoms have been seen in patients confirmed to have COVID-19 disease.Further discussion of these symptoms may provide insight into short-and long-term management for these patients...Background:Otologic and vestibular symptoms have been seen in patients confirmed to have COVID-19 disease.Further discussion of these symptoms may provide insight into short-and long-term management for these patients.Objective:The aim of this review was to describe the otologic and vestibular symptoms that present in patients with COVID-19.The primary outcomes of this review were onset,duration and clinical outcomes of these symptoms.Sources of Evidence:Pub Med,APAMed Central,Herdin,CINAHL,Scopus,Springer Link,ProQuest Coronavirus Research Database,and Google Scholar were searched for the articles to be included.Eligibility Criteria:Studies included were those involving adult patients diagnosed with COVID-19 who experienced hearing loss,ear pain,ear discharge,otitis media,vertigo,or tinnitus.Studies were eligible for inclusion if there was a description of the otologic dysfunction,specifically onset,duration,or clinical outcomes.Results:The majority of patients who experienced hearing loss(68%),tinnitus(88%),vertigo/dizziness(30%),ear pain(8%),and discharge(100%)did so within a month of experiencing the typical symptoms of COVID-19.A majority also experienced complete resolution of their symptoms within 2 weeks.Standard treatment for COVID-19 was usually provided but when specific diagnoses are made for these symptoms(e.g.,sudden sensorineural hearing loss,otitis media,vestibular neuritis),they are treated in the same manner as one would for non-COVID-19 cases,in addition to the management for COVID-19.In certain cases,there may be a need for additional work-up to rule out other causes.Conclusions:Otologic and vestibular symptoms were present in COVID-19 patients,majority as part of the systemic nature of the disease.The onset,duration,and course were consistent with the natural history of a systemic viral infection.COVID-19 should be considered in any patient with a new-onset hearing loss,tinnitus,or vertigo/dizziness,even in the absence of infectious or respiratory symptoms.展开更多
文摘Background:Otologic and vestibular symptoms have been seen in patients confirmed to have COVID-19 disease.Further discussion of these symptoms may provide insight into short-and long-term management for these patients.Objective:The aim of this review was to describe the otologic and vestibular symptoms that present in patients with COVID-19.The primary outcomes of this review were onset,duration and clinical outcomes of these symptoms.Sources of Evidence:Pub Med,APAMed Central,Herdin,CINAHL,Scopus,Springer Link,ProQuest Coronavirus Research Database,and Google Scholar were searched for the articles to be included.Eligibility Criteria:Studies included were those involving adult patients diagnosed with COVID-19 who experienced hearing loss,ear pain,ear discharge,otitis media,vertigo,or tinnitus.Studies were eligible for inclusion if there was a description of the otologic dysfunction,specifically onset,duration,or clinical outcomes.Results:The majority of patients who experienced hearing loss(68%),tinnitus(88%),vertigo/dizziness(30%),ear pain(8%),and discharge(100%)did so within a month of experiencing the typical symptoms of COVID-19.A majority also experienced complete resolution of their symptoms within 2 weeks.Standard treatment for COVID-19 was usually provided but when specific diagnoses are made for these symptoms(e.g.,sudden sensorineural hearing loss,otitis media,vestibular neuritis),they are treated in the same manner as one would for non-COVID-19 cases,in addition to the management for COVID-19.In certain cases,there may be a need for additional work-up to rule out other causes.Conclusions:Otologic and vestibular symptoms were present in COVID-19 patients,majority as part of the systemic nature of the disease.The onset,duration,and course were consistent with the natural history of a systemic viral infection.COVID-19 should be considered in any patient with a new-onset hearing loss,tinnitus,or vertigo/dizziness,even in the absence of infectious or respiratory symptoms.
